Results 21 to 30 of about 334,546 (308)

Bone marrow transplants

open access: yesBMJ, 2002
Bone marrow, or haematopoietic stem cell, transplants were originally developed to allow the use of very high dose treatments for malignancies such as leukaemia. Their use was based on the ideathat the high dose treatment might overcome inherent resistance of the malignancy to chemotherapy or radiotherapy. Transplants of stem cells from either the same
Johnson, Peter W. M., Orchard, Kim
openaire   +3 more sources

Self-renewal of colony forming units (cfu) in serial bone marrow transplantation experiments [PDF]

open access: yes, 1972
The capacity of stem cells (CFU) for self‐renewal was tested by transplanting normal bone marrow (primary transplantation) and bone marrow which had been subjected to one or two earlier transplantations (secondary and tertiary transplantation) into ...
Dolmans, M.J.A.S., Vos, O.
core   +2 more sources

Hematopoietic progenitor cell content of vertebral body marrow used for combined solid organ and bone marrow transplantation [PDF]

open access: yes, 1995
While cadaveric vertebral bodies (VB) have long been proposed as a suitable source of bone marrow (BM) for transplantation (BMT), they have rarely been used for this purpose. We have infused VB BM immediately following whole organ (WO) transplantation to
Ball, ED   +6 more
core   +1 more source

Reversal of graft-versus-host disease with infusion of autologous bone marrow [PDF]

open access: yes, 1994
Graft-versus-host disease (GVHD) remains a major complication of bone marrow transplantation. This report describes reversal of GVHD by infusion of stored recipient bone marrow following combined liver-bone marrow allotransplantation.
Adriana Zeevi   +20 more
core   +1 more source

Esophageal Plasmacytoma Revealed by Persistent Hiccups: A Case Report and Literature Review

open access: yesCase Reports in Gastrointestinal Medicine, 2022
Introduction. Solitary extramedullary plasmacytoma (SEP) is a rare neoplasm that is derived from monoclonal proliferation of plasma cells in the soft tissues or organs arising outside the bone marrow.
Khaoula Khalil   +2 more
doaj   +1 more source

Growth of donor-derived dendritic cells from the bone marrow of murine liver auograft recipients in response to granulocyte/macrophage colony-stimulating factor [PDF]

open access: yes, 1995
Allografts of the liver, which has a comparatively heavy leukocyte content compared with other vascularized organs, are accepted permanently across major histocompatibility complex barriers in many murine strain combinations without immunosuppressive ...
Fu, F   +9 more
core   +1 more source

Clinicohematological and cytogenetic profile of myelodysplastic syndromes in Pakistan-compare and contrast

open access: yesMolecular Cytogenetics, 2017
Background Myelodysplastic syndromes (MDS) are clonal stem cell disorders exhibiting cytopenias, ineffective hematopoiesis and morphological dysplasia. Bone marrow cytogenetics, inspite of being incorporated as mandatory tool in diagnosis are done less ...
Nida Anwar   +7 more
doaj   +1 more source

NPM1-Mutated Acute Myeloid Leukemia with Uterine Myeloid Sarcoma: A Diagnostic Challenge [PDF]

open access: yesDocumenta Haematologica
Introduction: Acute myeloid leukemia( AML) NPM1+ represents a distinct entity, frequently associated with normal cytogenetics and favorable prognosis in the absence of other adverse mutations.
Daiana TUNARU   +7 more
doaj   +1 more source

Targeting the Spleen as an Alternative Site for Hematopoiesis [PDF]

open access: yes, 2019
Bone marrow is the main site for hematopoiesis in adults. It acts as a niche for hematopoietic stem cells (HSC) and contains non-hematopoietic cells that contribute to stem cell dormancy, quiescence, self-renewal and differentiation.
Lim, Hong   +3 more
core   +1 more source

Case Report: Invasive Fungal Infection and Daratumumab: A Case Series and Review of Literature

open access: yesFrontiers in Oncology, 2022
Life expectancy of multiple myeloma (MM) patients has improved in last years due to the advent of anti-CD38 monoclonal antibodies in combination with immunomodulators and proteasome inhibitors.
Francesca Farina   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy